DOI QR코드

DOI QR Code

급성일산화탄소 중독환자에서 고압산소치료의 압력에 따른 예후 비교

Comparison of hyperbaric oxygen therapy pressures for acute carbon monoxide poisoning

  • 김정윤 (연세대학교 원주의과대학 응급의학교실) ;
  • 임지혜 (연세대학교 원주의과대학 의통계학과) ;
  • 김성화 (연세대학교 원주의과대학 의통계학과) ;
  • 한상일 (연세대학교 원주의과대학 응급의학교실) ;
  • 차용성 (연세대학교 원주의과대학 응급의학교실)
  • Jeong Yun Kim (Department of Emergency Medicine, Yonsei University Wonju College of Medicine) ;
  • Jihye Lim (Department of Biostatistics and Center of Biomedical Data Science, Yonsei University Wonju College of Medicine) ;
  • Sung Hwa Kim (Department of Biostatistics and Center of Biomedical Data Science, Yonsei University Wonju College of Medicine) ;
  • Sang Il Han (Department of Emergency Medicine, Yonsei University Wonju College of Medicine) ;
  • Yong Sung Cha (Department of Emergency Medicine, Yonsei University Wonju College of Medicine)
  • 투고 : 2023.09.14
  • 심사 : 2023.10.04
  • 발행 : 2023.12.31

초록

Purpose: No consensus currently exists regarding the maximal pressure of hyperbaric oxygen (HBO2) therapy performed within 24 hours of acute carbon monoxide (CO) poisoning. This study aimed to evaluate the difference in therapeutic effects according to the first HBO2 pressure (3.0 atmospheres absolute [ATA] vs. 2.8 ATA). Methods: We used prospectively collected registry data on CO poisoning at a tertiary academic hospital in the Republic of Korea. Adult patients with acute CO poisoning treated with HBO2 within 24 hours after arrival at the emergency department and without the use of additional HBO2 after 24 hours between January 2007 and February 2022 were included. Data from 595 patients were analyzed using propensity score matching (PSM). Patients with mild (non-intubated) and severe (intubated) poisoning were also compared. Neurocognitive outcomes at 1 month after CO poisoning were evaluated using the Global Deterioration Scale combined with neurological impairment. Results: After PSM, the neurocognitive outcomes at 1-month post-CO exposure were not significantly different between the 2.8 ATA (110 patients) and 3.0 ATA (55 patients) groups (p=1.000). Similarly, there was also no significant difference in outcomes in a subgroup analysis according to poisoning severity in matched patients (165 patients) (mild [non-intubated]: p=0.053; severe [intubated]: p=1.000). Conclusion: Neurocognitive sequelae at 1 month were not significantly different between HBO2 therapy pressures of 2.8 ATA and 3.0 ATA in patients with acute CO poisoning. In addition, the 1-month neurocognitive sequelae did not differ significantly between intubated and non-intubated patients.

키워드

과제정보

This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT) (Project Number: RS-2020-KD000247).

참고문헌

  1. Raub JA, Mathieu-Nolf M, Hampson NB, Thom SR. Carbon monoxide poisoning: a public health perspective. Toxicology 2000;145:1-14. https://doi.org/10.1016/s0300-483x(99)00217-6 
  2. Hampson NB, Weaver LK. Carbon monoxide poisoning: a new incidence for an old disease. Undersea Hyperb Med 2007;34:163-8. 
  3. Hampson NB. U.S. mortality due to carbon monoxide poisoning, 1999-2014: accidental and intentional deaths. Ann Am Thorac Soc 2016;13:1768-74. https://doi.org/10.1513/AnnalsATS.201604-318OC 
  4. Weaver LK, Hopkins RO, Chan KJ, Churchill S, Elliott CG, Clemmer TP, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 2002;347:1057-67. https://doi.org/10.1056/NEJMoa013121 
  5. Thom SR, Taber RL, Mendiguren II, Clark JM, Hardy KR, Fisher AB. Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen. Ann Emerg Med 1995;25:474-80. https://doi.org/10.1016/s0196-0644(95)70261-x 
  6. Weaver LK. Carbon monoxide poisoning. In: Moon RE, editors. Hyperbaric oxygen therapy indications. 14th ed. North Palm Beach (FL): Best Publishing Company; 2019. p. 81-104. 
  7. Thom SR, Mendiguren I, Hardy K, Bolotin T, Fisher D, Nebolon M, et al. Inhibition of human neutrophil beta2-integrin-dependent adherence by hyperbaric O2. Am J Physiol 1997;272(3 Pt 1):C770-7. https://doi.org/10.1152/ajpcell.1997.272.3.C770 
  8. Raphael JC, Elkharrat D, Jars-Guincestre MC, Chastang C, Chasles V, Vercken JB, et al. Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 1989;2:414-9. https://doi.org/10.1016/s0140-6736(89)90592-8 
  9. Annane D, Chadda K, Gajdos P, Jars-Guincestre MC, Chevret S, Raphael JC. Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials. Intensive Care Med 2011;37:486-92. https://doi.org/10.1007/s00134-010-2093-0 
  10. Ducasse JL, Celsis P, Marc-Vergnes JP. Non-comatose patients with acute carbon monoxide poisoning: hyperbaric or normobaric oxygenation? Undersea Hyperb Med 1995;22:9-15. 
  11. Lee Y, Cha YS, Kim SH, Kim H. Effect of hyperbaric oxygen therapy initiation time in acute carbon monoxide poisoning. Crit Care Med 2021;49:e910-9. https://doi.org/10.1097/CCM.0000000000005112 
  12. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-9. https://doi.org/10.1176/ajp.139.9.1136 
  13. Haukoos JS, Lewis RJ. The propensity score. JAMA 2015; 314:1637-8. https://doi.org/10.1001/jama.2015.13480 
  14. Austin PC. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol 2010;172:1092-7. https://doi.org/10.1093/aje/kwq224 
  15. Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011;10:150-61. https://doi.org/10.1002/pst.433 
  16. Rubin DB. Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol 2001;2:169-88. https://doi.org/10.1023/A:1020363010465 
  17. Hampson NB, Simonson SG, Kramer CC, Piantadosi CA. Central nervous system oxygen toxicity during hyperbaric treatment of patients with carbon monoxide poisoning. Undersea Hyperb Med 1996;23:215-9. 
  18. Thom SR, Bhopale VM, Han ST, Clark JM, Hardy KR. Intravascular neutrophil activation due to carbon monoxide poisoning. Am J Respir Crit Care Med 2006;174:1239-48. https://doi.org/10.1164/rccm.200604-557OC 
  19. Piantadosi CA, Zhang J, Levin ED, Folz RJ, Schmechel DE. Apoptosis and delayed neuronal damage after carbon monoxide poisoning in the rat. Exp Neurol 1997;147:103-14. https://doi.org/10.1006/exnr.1997.6584 
  20. Thom SR, Bhopale VM, Fisher D, Zhang J, Gimotty P. Delayed neuropathology after carbon monoxide poisoning is immune-mediated. Proc Natl Acad Sci U S A 2004;101:13660-5. https://doi.org/10.1073/pnas.0405642101 
  21. Thom SR. Functional inhibition of leukocyte B2 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats. Toxicol Appl Pharmacol 1993;123:248-56. https://doi.org/10.1006/taap.1993.1243 
  22. Hampson NB, Dunford RG, Ross DE, Wreford-Brown CE. A prospective, randomized clinical trial comparing two hyperbaric treatment protocols for carbon monoxide poisoning. Undersea Hyperb Med 2006;33:27-32. 
  23. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-81. https://doi.org/10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b 
  24. Kim SJ, Thom SR, Kim H, Hwang SO, Lee Y, Park EJ, et al. Effects of adjunctive therapeutic hypothermia combined with hyperbaric oxygen therapy in acute severe carbon monoxide poisoning. Crit Care Med 2020;48:e706-14. https://doi.org/10.1097/CCM.0000000000004419 
  25. Cho DH, Ko SM, Son JW, Park EJ, Cha YS. Myocardial injury and fibrosis from acute carbon monoxide poisoning: a prospective observational study. JACC Cardiovasc Imaging 2021;14:1758-70. https://doi.org/10.1016/j.jcmg.2021.02.020